Augmedix, Inc. Common Stock
AUGX
AUGX was delisted on the 1st of October, 2024.
84 hedge funds and large institutions have $162M invested in Augmedix, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 18 reducing their positions, and 19 closing their positions.
106% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 18
7% more call options, than puts
Call options by funds: $2.21M | Put options by funds: $2.07M
0% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 19
1% less funds holding
Funds holding: 85 → 84 (-1)
23% less capital invested
Capital invested by funds: $209M → $162M (-$47.4M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$8.13M |
| 2 |
SM
Samjo Management
New York
|
+$4.48M |
| 3 |
RPAM
Rhenman & Partners Asset Management
Stockholm,
Sweden
|
+$3.58M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3.06M |
| 5 |
Millennium Management
New York
|
+$2.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DSCM
Divisadero Street Capital Management
Miami,
Florida
|
-$7.55M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.55M |
| 3 |
AIC
AWM Investment Company
New York
|
-$1.44M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$1.23M |
| 5 |
Vontobel Holding
Zurich,
Switzerland
|
-$1.1M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
QT
101
Quantbot Technologies
New York
| – | -$65.1K | -11,120 | Closed |
|
102
Osaic Holdings
Scottsdale,
Arizona
| – | -$9.74K | -1,665 | Closed |
|
103
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1K | -97 | Closed |
|
AUGX Hedge Fund Activity: Q1 2024 in Review
84 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Augmedix, Inc. Common Stock (AUGX) for Q1 2024, worth a combined $162M — down 23% from $209M a quarter earlier.
Fund positioning in AUGX was balanced in Q1 2024: 19 funds opened new positions, 19 closed out, 37 added to existing stakes and 18 trimmed.
The largest buyer was Citadel Advisors, adding an estimated $8.13M. The largest seller was Divisadero Street Capital Management, cutting an estimated $7.55M.
- 84 institutional investors held Augmedix, Inc. Common Stock (AUGX) as of Q1 2024, down from 85 in Q4 2023.
- Funds reported $162M of Augmedix, Inc. Common Stock stock for Q1 2024, down 23% quarter-over-quarter.
- 19 funds opened new Augmedix, Inc. Common Stock positions in Q1 2024 and 19 closed out, a net change of 0 holders.
- The largest Augmedix, Inc. Common Stock buyer in Q1 2024 was Citadel Advisors, an estimated $8.13M added.
- The largest Augmedix, Inc. Common Stock seller in Q1 2024 was Divisadero Street Capital Management, an estimated $7.55M sold.
Based on aggregated 13F filings for Q1 2024.